SAFESTEREO: phase II randomized trial to compare stereotactic radiosurgery with fractionated stereotactic radiosurgery for brain metastases.
Crouzen JA, Petoukhova AL, Broekman MLD, Fiocco M, Fisscher UJ, Franssen JH, Gadellaa-van Hooijdonk CGM, Kerkhof M, Kiderlen M, Mast ME, van Rij CM, Nandoe Tewarie R, van de Sande MAE, van der Toorn PPG, Vlasman R, Vos MJ, van der Voort van Zyp NCMG, Wiggenraad RGJ, Wiltink LM, Zindler JD.
Crouzen JA, et al. Among authors: fisscher uj.
BMC Cancer. 2023 Mar 25;23(1):273. doi: 10.1186/s12885-023-10761-1.
BMC Cancer. 2023.
PMID: 36964529
Free PMC article.
Clinical Trial.